125.55MMarket Cap-5470P/E (TTM)
4.900High4.100Low132.68KVolume4.900Open4.470Pre Close577.12KTurnover0.76%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High282.67P/B74.05MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM17.90%Amplitude3.110Historical Low4.349Avg Price1Lot Size
Telomir Pharmaceuticals Stock Forum
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Telomir Pharmaceuticals (NASDAQ:TELO) has been featured in a local ABC exclusive highlighting promising age reversal outcomes in two senior dogs using their novel small molecule, Telomir-1. The compassionate use program, observed by Dr. Michael Roizen, showed remarkable improvements in the dogs' health and vitality. Zeus, a 12-year-old Ger...
NEWS
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
Telomir Pharmaceuticals presents promising pre-clinical data on Telomir-1 at a National Press Club event, showcasing a 40% increase in telomerase activity and lengthening of telomeres in human cells. The company plans to initiate human clinical trials for osteoarthritis and veterinary trials in 2025 after pre-clinical...
No comment yet